These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 7708684)

  • 21. Imbalanced expression of cellular nuclear oncogenes caused by v-sis/PDGF-2.
    Sonobe MH; Bravo R; Armelin MS
    Oncogene; 1991 Sep; 6(9):1531-7. PubMed ID: 1923519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation.
    Kovalenko M; Gazit A; Böhmer A; Rorsman C; Rönnstrand L; Heldin CH; Waltenberger J; Böhmer FD; Levitzki A
    Cancer Res; 1994 Dec; 54(23):6106-14. PubMed ID: 7954456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of extracellular signals and cell proliferation by the black tea polyphenol, theaflavin-3,3'-digallate.
    Liang YC; Chen YC; Lin YL; Lin-Shiau SY; Ho CT; Lin JK
    Carcinogenesis; 1999 Apr; 20(4):733-6. PubMed ID: 10223207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of herbimycin A on tyrosine kinase receptors and platelet derived growth factor (PDGF)-induced signal transduction.
    Murakami Y; Fukazawa H; Mizuno S; Uehara Y
    Biol Pharm Bull; 1998 Oct; 21(10):1030-5. PubMed ID: 9821805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Divergence in signal transduction pathways of platelet-derived growth factor (PDGF) and epidermal growth factor (EGF) receptors. Involvement of sphingosine 1-phosphate in PDGF but not EGF signaling.
    Rani CS; Wang F; Fuior E; Berger A; Wu J; Sturgill TW; Beitner-Johnson D; LeRoith D; Varticovski L; Spiegel S
    J Biol Chem; 1997 Apr; 272(16):10777-83. PubMed ID: 9099730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class.
    Kilic T; Alberta JA; Zdunek PR; Acar M; Iannarelli P; O'Reilly T; Buchdunger E; Black PM; Stiles CD
    Cancer Res; 2000 Sep; 60(18):5143-50. PubMed ID: 11016641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571.
    McGary EC; Weber K; Mills L; Doucet M; Lewis V; Lev DC; Fidler IJ; Bar-Eli M
    Clin Cancer Res; 2002 Nov; 8(11):3584-91. PubMed ID: 12429650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. v-mos suppresses platelet-derived growth factor (PDGF) type-beta receptor autophosphorylation and inhibits PDGF-BB-mediated signal transduction.
    Faller DV; Mundschau LJ; Forman LW; Quiñones MA
    J Biol Chem; 1994 Feb; 269(7):5022-9. PubMed ID: 8106477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferons block protein kinase C-dependent but not-independent activation of Raf-1 and mitogen-activated protein kinases and mitogenesis in NIH 3T3 cells.
    Xu J; Rockow S; Kim S; Xiong W; Li W
    Mol Cell Biol; 1994 Dec; 14(12):8018-27. PubMed ID: 7526152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of platelet-derived growth factor receptor tyrosine kinase and downstream signaling pathways by Compound C.
    Kwon HJ; Kim GE; Lee YT; Jeong MS; Kang I; Yang D; Yeo EJ
    Cell Signal; 2013 Apr; 25(4):883-97. PubMed ID: 23277201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines.
    Traxler P; Bold G; Frei J; Lang M; Lydon N; Mett H; Buchdunger E; Meyer T; Mueller M; Furet P
    J Med Chem; 1997 Oct; 40(22):3601-16. PubMed ID: 9357527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R.
    Traxler P; Furet P; Mett H; Buchdunger E; Meyer T; Lydon N
    J Pharm Belg; 1997; 52(2):88-96. PubMed ID: 9193132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A potent protein-tyrosine kinase inhibitor which selectively blocks proliferation of epidermal growth factor receptor-expressing tumor cells in vitro and in vivo.
    Lydon NB; Mett H; Mueller M; Becker M; Cozens RM; Stover D; Daniels D; Traxler P; Buchdunger E
    Int J Cancer; 1998 Mar; 76(1):154-63. PubMed ID: 9533776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of growth factor-mediated tyrosine phosphorylation in vascular smooth muscle by PD 089828, a new synthetic protein tyrosine kinase inhibitor.
    Dahring TK; Lu GH; Hamby JM; Batley BL; Kraker AJ; Panek RL
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1446-56. PubMed ID: 9190882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
    Rewcastle GW; Murray DK; Elliott WL; Fry DW; Howard CT; Nelson JM; Roberts BJ; Vincent PW; Showalter HD; Winters RT; Denny WA
    J Med Chem; 1998 Feb; 41(5):742-51. PubMed ID: 9513602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dermatofibrosarcoma protuberans-associated collagen type Ialpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB.
    Shimizu A; O'Brien KP; Sjöblom T; Pietras K; Buchdunger E; Collins VP; Heldin CH; Dumanski JP; Ostman A
    Cancer Res; 1999 Aug; 59(15):3719-23. PubMed ID: 10446987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitors of protein tyrosine phosphorylation reduce the proliferation of two human glioma cell lines.
    Oude Weernink PA; Verheul E; Kerkhof E; van Veelen CW; Rijksen G
    Neurosurgery; 1996 Jan; 38(1):108-13; discussion 113-4. PubMed ID: 8747958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Membrane-anchored form of v-sis/PDGF-B induces mitogenesis without detectable PDGF receptor autophosphorylation.
    Lee BA; Donoghue DJ
    J Cell Biol; 1991 Apr; 113(2):361-70. PubMed ID: 1849139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and tyrosine kinase inhibitory activity of a series of 2-amino-8H-pyrido[2,3-d]pyrimidines: identification of potent, selective platelet-derived growth factor receptor tyrosine kinase inhibitors.
    Boschelli DH; Wu Z; Klutchko SR; Showalter HD; Hamby JM; Lu GH; Major TC; Dahring TK; Batley B; Panek RL; Keiser J; Hartl BG; Kraker AJ; Klohs WD; Roberts BJ; Patmore S; Elliott WL; Steinkampf R; Bradford LA; Hallak H; Doherty AM
    J Med Chem; 1998 Oct; 41(22):4365-77. PubMed ID: 9784112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-derived growth factor (PDGF) B and A homodimers transform murine fibroblasts depending on the genetic background of the cell.
    Kim HR; Upadhyay S; Korsmeyer S; Deuel TF
    J Biol Chem; 1994 Dec; 269(48):30604-8. PubMed ID: 7982979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.